GMFR in IgG titer;GMFR in neutralizing antibody;GMT of neutralizing antibody;GMT of S-specific, RBD-specific, and N-specific antibodies;Incidence and severity of solicited local reactogenicity AEs;Incidence and severity of solicited systemic reactogenicity AEs;Incidence and severity of unsolicited AEs;Incidence and severity of unsolicited AEs;Incidence of changes of laboratory safety examinations;Incidence of MAAEs and SAEs;Incidence of MAAEs and SAEs;Percentage of participants who seroconverted;Seroconversion rate of neutralizing antibody;Vital Sign - Blood Pressure;Vital Sign - Heart rate;Vital Sign - Respiratory Rate;Vital Sign - Temperature

GMFR in IgG titer;GMFR in neutralizing antibody;GMT of neutralizing antibody;GMT of S-specific, RBD-specific, and N-specific antibodies;Incidence and severity of solicited local reactogenicity AEs;Incidence and severity of solicited systemic reactogenicity AEs;Incidence and severity of unsolicited AEs;Incidence and severity of unsolicited AEs;Incidence of changes of laboratory safety examinations;Incidence of MAAEs and SAEs;Incidence of MAAEs and SAEs;Percentage of participants who seroconverted;Seroconversion rate of neutralizing antibody;Vital Sign - Blood Pressure;Vital Sign - Heart rate;Vital Sign - Respiratory Rate;Vital Sign - Temperature